Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 13, 2023

SELL
$144.61 - $166.54 $25,740 - $29,644
-178 Reduced 10.9%
1,455 $232 Million
Q4 2022

Apr 05, 2023

BUY
$138.31 - $165.87 $225,860 - $270,865
1,633 New
1,633 $264 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $337B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Eaton Financial Holdings Company, LLC Portfolio

Follow Eaton Financial Holdings Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Financial Holdings Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Financial Holdings Company, LLC with notifications on news.